Regulators & approval

Q: Does “FDA-approved” mean a compound is safe?

It means a regulator judged that, for a specific condition and dose , the benefits outweigh the risks on the strength of controlled trials — not that it is safe in general, or safe used off-label, or safe for you. Approval is always tied to an indication; the same drug used for something else is a different risk question.

Every entry carries a status label — approved drug, research chemical, cosmetic ingredient, supplement. This is what those labels rest on: who decides, what “approved” means, and the ways a compound can look more official than it is.

This page is about the approval machinery and what the labels mean. Whether a compound is legal for you to buy or hold is a separate question, covered on the legal status page.

Who the regulators are

A medicine reaches the market only after a national or regional authority reviews the evidence and grants a marketing authorisation. The ones that recur on this site are the FDA in the United States, the EMA for the European Union, and the UK’s MHRA. They assess independently, so approval is always per jurisdiction — a fact the entries preserve by naming the country rather than saying “approved” flatly.

What “approved” means — and does not

Approval is a judgement that, for a named condition at a named dose, the benefits outweigh the risks, on the strength of controlled trials — and it is almost always prescription-only. It is not a statement that the drug is safe in general, safe for a different use, or safe for everyone. Using an approved drug off-label is lawful for a doctor but steps outside what the evidence and the approval actually cover.

Three ways a compound looks more official than it is

Accelerated approval a surrogate, not an outcome: The FDA can approve a drug on a surrogate endpoint — a lab marker reasonably likely to predict benefit — with a confirmatory trial still required afterwards. It is a real approval, but the benefit that matters has not yet been proven. Elamipretide (Forzinity), approved in 2025 for Barth syndrome on a muscle-strength measure, is exactly this case: approved, with the confirmatory trial still outstanding.
Orphan designation designation ≠ authorisation: A status for drugs aimed at rare diseases that brings incentives to develop them. It is frequently quoted as if it were approval; it is not. The EMA states plainly that an orphan designation does not mean a medicine is authorised.
Compounding (503A / 503B) prepared, not approved: Making a medicine outside mass manufacturing — for one prescription (503A) or in bulk by an outsourcing facility (503B). Useful and legitimate, but a compounded product is not an FDA-approved product, and “available from a compounding pharmacy” is not the same as approved.

How the status labels map to this

Approved drug: Holds a marketing authorisation from a recognised regulator for at least one indication. The country and indication are what matter, not the word alone.
Research chemical: Not approved as a medicine anywhere relevant; sold “not for human use” and made without pharmaceutical quality control.
Cosmetic ingredient: Regulated as a cosmetic, not a medicine — a much lower bar, and only for topical use; injecting it is off any approval entirely.
Supplement: Sold under food/supplement rules, which do not require pre-market proof of efficacy and do not make a medical claim lawful.
Endogenous peptide: A substance the body makes itself. That says nothing about whether a manufactured product containing it is approved, safe or legal.

Regulators & approval: common questions

Does “FDA-approved” mean a compound is safe?

It means a regulator judged that, for a specific condition and dose, the benefits outweigh the risks on the strength of controlled trials — not that it is safe in general, or safe used off-label, or safe for you. Approval is always tied to an indication; the same drug used for something else is a different risk question.

What does “research chemical” actually mean?

That no regulator has approved it as a medicine, and it is sold labelled “not for human use” to sit outside medicines law. It is not made or released under pharmaceutical quality control, so identity, purity and sterility are not guaranteed. The label is a legal device, not a statement about the compound — see legal status.

If a drug is approved in the US, is it approved in the EU?

Not automatically. The FDA, the EMA and the UK’s MHRA are separate authorities that assess and approve independently, so a medicine can be approved in one place, refused in another, and merely “designated” in a third. Status is per-jurisdiction, which is why the entries name the country.

What is compounding, and is a compounded product FDA-approved?

Compounding is preparing a medicine outside mass manufacturing — 503A pharmacies for an individual prescription, 503B outsourcing facilities in bulk. Neither produces an FDA-approved product; a compounded version of an approved drug has not itself been through approval.

Legal status · What a lab test proves · Doping status · Glossary